Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion
Shreya Sengupta(Cleveland Clinic), Yan Xu(Qingdao University), Bryan Williams(The London College), Kyungdo Kim(Cleveland Clinic), Willis X. Li(University of Rochester Medical Center), Jerome L. Belinson(Cleveland Clinic), Pedro F. Escobar(San Juan Bautista School of Medicine), Michael Berk(The Royal Melbourne Hospital), Robert D. Oates(Cleveland Clinic), Daniel J. Lindner(Cleveland Clinic)
Cited by 63
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.4k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
So depression is an inflammatory disease, but where does the inflammation come from?
|BMC Medicine|2013|1.4k